Form 4: Terns Pharmaceuticals' Chief Medical Officer Sells Shares to Cover Tax Obligations

Emil Kuriakose, Chief Medical Officer of Terns Pharmaceuticals, sold 952 shares of common stock on April 1, 2025, to cover taxes related to a restricted stock unit vesting.

Summary

• On April 1, 2025, Emil Kuriakose, the Chief Medical Officer of Terns Pharmaceuticals, sold 952 shares of the company's common stock.
• The sale was executed to satisfy tax obligations arising from the vesting of a previously granted restricted stock unit award.
• The shares were sold at a weighted average price ranging from $2.475 to $2.54 per share.
• Following the transaction, Kuriakose directly owns 53,317 shares of Terns Pharmaceuticals.
• The sale was not a discretionary trade but rather a necessary action to cover tax liabilities.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (sale of shares to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects. It's a neutral event.

Industry Context

Sales of shares to cover tax obligations after vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Key Dates

Keywords

Terns Pharmaceuticals, Emil Kuriakose, Chief Medical Officer, stock sale, Form 4, restricted stock unit, tax obligations, TERN